Impact of Plasma Indoxyl Sulfate on One-year Adverse Events in Chronic Kidney Disease Patients with Heart Failure: a Prospective, Multicenter Cohort Study
Not Applicable
- Conditions
- Heart failure Chronic kidney disease
- Registration Number
- JPRN-UMIN000035850
- Lead Sponsor
- Okayama University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 312
Inclusion Criteria
Not provided
Exclusion Criteria
1)history of hospitalization within 30 days 2)patient taking spherical carbonaceous adsorbent 3)patient on hemodialysis 4)patient with Nephrotic Syndrome 5)patient wiht polysistic kidney 6)patient who took any unaprooved medicine wihtin 180 days 7)patient wiht prognosis less than 12 months 8)woman who is pregnant 9)patient who is unsuitable for this study by the investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of all cause death, non fatal myocardial infarction, non fatal stroke, and hospitalization for heart failure during one-year follow up after acquisition of indoxyl sulfate concentration.
- Secondary Outcome Measures
Name Time Method